Transforming drug discovery with a high-throughput AI-powered platform: A 5-year experience with Patrimony.

Blaudin de Thé, François-Xavier; Baudier, Claire; Andrade Pereira, Renan; Lefebvre, Céline; Moingeon, Philippe

Blaudin de Thé, François-Xavier; Baudier, Claire; Andrade Pereira, Renan; Lefebvre, Céline; Moingeon, Philippe.

Afiliação

Blaudin de Thé FX; Servier Research & Development, Saclay, France.
Baudier C; Servier Research & Development, Saclay, France.
Andrade Pereira R; Servier Data Factory, Suresnes, France.
Lefebvre C; Servier Research & Development, Saclay, France.
Moingeon P; Servier Research & Development, Saclay, France. Electronic address: philippe.moingeon@servier.com.

Drug Discov Today ; 28(11): 103772, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37717933

Assuntos

Inteligência Artificial; Descoberta de Drogas; Humanos; Pesquisadores

Palavras-chave

artificial intelligence; computational precision medicine; data integration; drug discovery; industrialization; target identification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google